Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim

Endocrinol Metab. 2019;34(1):80-92. Published online March 21, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.1.80

Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis

K. Gooßen, S. Gräber

Diabetes, Obesity and Metabolism. 2012;14(12):1061-1072

Link1

Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim

Endocrinology and Metabolism. 2019;34(1):80

Link1 Link2 Link3

Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus

Masayuki Kaneko, Mamoru Narukawa

Diabetes Research and Clinical Practice. 2016;116:171-182

Link1 Link2

The Effect of Dipeptidyl Peptidase-4 Inhibitors on Carotid Intima-media Thickness in Patients With Type 2 Diabetes Mellitus: a Meta-analysis

Hua-song Xia, Yue Liu, Yang Fu, Meng Li, Yan-qing Wu

. 2020;

Link1 Link2

Short-term and long-term effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with renal impairment: a meta-analysis of randomized controlled trials

Ruifei Li, Rui Wang, Haixia Li, Sihao Sun, Meijuan Zou, Gang Cheng

Diabetes/Metabolism Research and Reviews. 2015;32(6):460-469

Link1 Link2

Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis

F. Barkas, M. Elisaf, V. Tsimihodimos, H. Milionis

Diabetes & Metabolism. 2017;43(1):1-8

Link1 Link2

Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis

P. Men, N. He, C. Song, S. Zhai

Diabetes & Metabolism. 2017;43(6):493-500

Link1 Link2

Renal outcomes with dipeptidyl peptidase-4 inhibitors

A.J. Scheen, P. Delanaye

Diabetes & Metabolism. 2018;44(2):101-111

Link1 Link2

Effect of Dipeptidyl Peptidase-4 Inhibitors on Hemoglobin a1c In Patients with Type 2 Diabetes Mellitus and Renal Impairment: a Systematic Review and Meta-analysis

D. Singh-Franco, C. Harrington, E. Tellez-Corrales

Value in Health. 2015;18(3):A55

Link1 Link2

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis

Dongsheng Cheng, Yang Fei, Yumei Liu, Junhui Li, Yuqiang Chen, Xiaoxia Wang, Niansong Wang

PLoS ONE. 2014;9(10):e111543

Link1